Patellar Tendinitis Clinical Trial
Official title:
Comparative Effects of Large Focused and Controlled Unfocused (Radial) Extracorporeal Shock Wave Therapies in the Treatment of Patellar Tendinopathy.
Verified date | January 2023 |
Source | Yuzuncu Yil University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There is no scientific study in the literature regarding the use of different extracorporeal shock wave therapies (ESWT) in the treatment of patellar tendinopathy. In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in the treatment of patellar tendinopathy.
Status | Completed |
Enrollment | 75 |
Est. completion date | December 19, 2022 |
Est. primary completion date | November 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Engaging in active sports, being 18 years or older, history of activity-related knee pain in the patellar tendon or patellar insertion, symptoms lasting longer than 8 weeks (non-acute), VISA-P score less than 80 before treatment, pain during knee loading on tendon or tendon it remains isolated in the limited part of the bone junction and does not spread to the entire patellar region (to differentiate patellar tendinopathy and patellofemoral pain). Exclusion Criteria: - Being under the age of 18, acute knee or acute patellar tendon injury, chronic inflammatory joint diseases (rheumatoid arthritis, etc.), using immunosuppressive or corticosteroid medication in the last 6 months, previous knee surgery (in the anterior cruciate ligament or patellar tendon), knee in the last 1 month local (corticosteroid) injection, contraindications for ESWT treatment (eg pregnancy, malignancy, coagulopathy), previous ESWT treatment |
Country | Name | City | State |
---|---|---|---|
Turkey | Yuzuncu Yil University | Van |
Lead Sponsor | Collaborator |
---|---|
Yuzuncu Yil University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual Analogue Scale (VAS) | patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse | at baseline. | |
Primary | Visual Analogue Scale (VAS) | patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse | 3 weeks after baseline. | |
Primary | Visual Analogue Scale (VAS) | patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse | 7 weeks after baseline. | |
Primary | Visual Analogue Scale (VAS) | patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse | 15 weeks after baseline. | |
Primary | Victorian Institute of Sports Assessment-Patella (VISA-P) | The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. | at baseline. | |
Primary | Victorian Institute of Sports Assessment-Patella (VISA-P) | The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. | 3 weeks after baseline. | |
Primary | Victorian Institute of Sports Assessment-Patella (VISA-P) | The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. | 7 weeks after baseline. | |
Primary | Victorian Institute of Sports Assessment-Patella (VISA-P) | The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies. Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire. Scores below 80 are usually indicative of patellar tendinopathy. | 15 weeks after baseline. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04153877 -
The Effect of Kinesio-tape® on Pain and Vertical Jump Performance in Active Individuals With Patellar Tendinopathy
|
||
Completed |
NCT04339569 -
Landing Biomechanics Following Fatigue in Athletes With and Without a History of Patellar Tendinopathy
|
||
Completed |
NCT03694730 -
Continued Activity During Rehabilitation in Patients With Patellar Tendinopathy
|
N/A | |
Completed |
NCT03528746 -
The Acute Effect of Isometric Versus Isotonic Resistance Exercise in Patients With Patellar Tendinopathy
|
N/A | |
Active, not recruiting |
NCT04753853 -
Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy
|
N/A | |
Completed |
NCT03917849 -
Efficacy of Inertial Flywheel vs Heavy Slow Resistance Training Among Athletes With Patellar Tendinopathy
|
N/A | |
Active, not recruiting |
NCT05538494 -
Effects on the Patellar Tendon After Low-load Blood Flow Restriction Training.
|
N/A | |
Completed |
NCT04219917 -
A Comparison of Kinesio® Taping Methods for Subjects With Patellar Tendonitis
|
N/A | |
Completed |
NCT04682496 -
Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy
|
N/A | |
Completed |
NCT03136965 -
Platelet-Rich Plasma Therapy for Patellar Tendinopathy
|
Phase 2 |